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This invention concerns a method for extending the survival

time of mammalian lung tissue subjected to ischemia, by
which said tissue is perfused with a preservation solution
comprising a therapeutic dose of the delta opioid DADLE

([D-Ala2,D-Leu5]-Enkephalin) under hypothermic condi
tions.
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METHOD FOR EMPLOYING THE DELTA
OPIOID DADLE TO EXTEND TISSUE
SURVIVAL TIME DURING ISCHEMIA

thermic atelectasis, hypothermic pulmonary artery ?ushing
and storage, with or without varying degrees of in?ation;
donor core cooling on cardiopulmonary bypass; and autop

erfused heart-lung preparation at norrnothermia.
Single-?ush perfusion of the lungs is currently the most

FIELD OF THE INVENTION

widely practiced technique in lung preservation. However,

During the past thirty years, several methods have been
developed for preserving solid organs for transplantation. In
almost all cases, such preservation methods have included
?ushing or perfusing organs with cold crystalloid or plasma

when simple ?ushing with preservation solution is used, the
result is always unsatisfactory. Even with many di?erent
additives and modi?cations to the solution, lung function is
severely compromised after more than 12 hours of preser

10

solutions. The recent introduction of the University of
\Vrsconsin Solution now permits kidneys to be stored for 72

hours and livers for 24 hours in animal studies. However,
safe preservation times for the heart and lungs are still
limited to 4 to 6 hours regardless of the solution used

vation. For years, numerous chemicals (such as

prostaglandins, oxygen free-radical scavengers, platelet acti
vating factor antagonists or leukocyte depletion,
15

corticosteroids, and other chemicals) have been added to
pulmonary artery ?ush solutions such as modi?ed Euro

(including University of Wisconsin Solution, Collins

Collins solution, University of Wisconsin solution, UCLA

Solution, Euro-Collins Solution, or these solutions with

DADLE ([D-Ala2, d-Leu5]-Enkephalin), could extend tissue
survival time substantially during normothermic multiple

solution, Stanford solution, and Bretschneider’s solution.
Although various reports have indicated that these added
chemicals provide improved e?rects, no additive has been
proved reliable. Our results from Group 2 (described
elsewhere) appear to agree with previous studies. Euro

organ preservation. Because very few groups in the world
use normothermic multiple organ techniques, the use of the

vasoconstriction, and the safe preservation time is usually 4

many additives).
In the last few years, our group found that a delta opioid,

DADLE in normothermic preparations is currently still
limited.

Collins solution alone is known to cause pulmonary
to 6 hours.
25

BACKGROUND OF THE INVENTION

An acute shortage of donor organs greatly limits access to

transplantation. As of Jul. 22, 1992, according to the United
Network for Organ Sharing (UNOS), 21,120 patients were

30

awaiting a kidney; 2,183 a liver; 783 a pancreas; 2,557 a

heart; 166 a heart-lung; and 889 a lung transplant. Since
December 1986, the demand for transplantation has

storage, the potential of adding positive eifects to presently
used preservation solutions will be tremendous. Not only

will this technique improve hypothermic organ preservation,
but it will also improve the effectiveness of various currently
used cardioplegic solutions and possibly of other hypother

in 1990, with variation according to the procedure required.
The paucity of donor organs for human transplantation

mic treatment modalities.

can be remedied to a certain extent by procuring organs from

'

SUMMARY OF THE INVENTION
45

would bene?t greatly, as has been the case for renal

This invention involves a method for extending the sur

vival time of mammalian lung tissue subjected to ischemia,
such as that which occurs during cardioplegia during open

transplantation, from the development of satisfactory meth
ods of organ preservation to extend the travel time of donor
organs.

heart surgery and treatment of shock. This method com
50

prises ?ushing the lung tissue with a preservation solution
comprising a therapeutic dose (e.g., 1 to 10 mg/Kg) of the

delta opioid DADLE ([D-Ala2, d-Leu5]-Enkephalin) and
then preserving the lung in hypothermia. The results
obtained have been very encouraging.
Our rat lung preservation study indicated that when

sometimes a period of ischernia of up to 9 hours is tolerated

with depressed lung function after transplant. Several inves
tigators have reported preservation for periods ranging from

extend tissue survival time in a normothermic multiorgan
preservation block. Because of technical dif?culties, normo
thermic multiple organ preparations are used by only a few

preparations is limited at the present time. However, if
DADLE can also extend tissue survival time in hypothermic

ents. Meanwhile, there has been little change in the supply
of organ donors. Between 1986 and 1991, the number of
donors has been between 4,000 and 4,500 annually. As a
result, the number of patients who die while awaiting a
transplant continues to increase: from 1,537 in 1988 to 2,077

The criteria for lung donors are very strict; only 10% to
15% of suitable heart donors will also be potential lung
donors. With current clinical methods of lung preservation,
4 to 6 hours of storage proves largely successful, and

transplanted, thus reducing or possibly eliminating the
necessity for immunosuppressive treatment of the recipient.
Our previous study showed that DADLE can eifectively

groups around the world; the use of DADLE in such

increased by 188%, from 9,632 to 27,678 potential recipi

distant sites, particularly from large urban areas where
accident rates are high. Heart and lung transplantations

Long-termpreservation of donor organs in vitro will also
make it possible to treat the donor organ before it is

55

DADLE was added to the Euro-Collins solution, the lungs
preserved for 24 hours maintained excellent function, a

20 to 48 hours, but none of these reports has been associated

result never achieved by previous reports using Euro-Collins

with consistent, reliable results, which would be required for

solution alone.

clinical application. Methods with such a short preservation

Severe pulmonary edema, hemorrhage, and occlusive
time have three primary disadvantages: (1) they limit the
pulmonary artery resistance occurred in Group 2 (without
geographic area from which grafts can be obtained; (2) they
DADLE) within 30 minutes of perfusion. Perfusion studies
limit the time available for histocompatibility tests; and (3)
were carried out for more than 60 minutes in Group 1
they increase the likelihood of inadequate organ function
(Normal) and Group 3 (with DADLE). Pulmonary blood
after transplantation.
, ?ow was lower in Group 2 than in either Group 1 or Group
Clinical methods used for lung preservation for transplan 65 3. Pulmonary vascular resistance (PVR) was much higher in
tation have included immediate implantation (donor trans
Group 2 than in Groups 1 and 3 (p<0.05, FIG. 1). Airway
ported to the hospital where the recipient is located); hypo
pressure and airway resistance (AWR) were much higher in

5,656,420
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Group 2 than in Group 1 and Group 3 (p<0.05). AWR was
also higher in Group 3 than in Group 1 after 20 minutes of

DETAILED DESCRIPTION OF THE
INVENTION
METHODS
Healthy adult rats (250 to 300 gm) were allowed free

perfusion (p<0.05. FIG. 2). Oxygen tensions from the pul
monary vein (pvO2) of the isolated lung in Group 2 were
lower than those in Group 1 and Group 3 (p<0.05, FIG. 3).

access to food and water before surgery. All animals

Alveolar-arterial oxygen difference was much higher in

received humane care in compliance with the “Principles of

Group 2 than in Group 1 and Group 3 (p<0.05, FIG. 4). Lung

Laboratory Animal Care” formulated by the National Soci

tissue wet/dry weight ratio after perfusion was much higher
in Group 2 than in Group 1 and Group 3 (FIG. 5). The most

Use of Laboratory Animals” prepared by the Institute of

ety for Medical Research and the “Guide for the Care and

Laboratory Animal Resources and published by the National
Institutes of Health (NIH publication No. 86-23, revised

interesting ?nding is the near-normal tissue wet/dryweight
ratio, pulmonary blood ?ow, pulmonary vascular resistance,
and oxygen transporting capacity of the lungs after 24-hour
preservation in the group using DADLE. In comparison with
normal lungs (without preservation), airway resistance in the
lungs preserved with DADLE increased slightly after pres

1985).
Preparation of hypothennic isolated lung storage:
15

The rats were anesthetized by intraperitoneal injection of
sodium pentobarbital (35 to 50 mg/kg wt). The cervical

of the lungs preserved with Euro-Collins solution alone.

trachea was cannulated, and each animal was ventilated by
a rodent respirator using room air. Tidal volume of 2.5 to 3.5
ml and rate of 40 to 50 rpm were maintained. The retroster

The results clearly demonstrate, for the ?rst time, that
DADLE can effectively enhance hypothermic lung preser

nal space was exposed by blunt dissection, and two large
straight clamps were applied in a parallel fashion across the

vation in rats.

sternum. Care was taken not to injure the lungs and vessels
beneath. The thorax was opened by median stemotomy.
After administration of 300 IU heparin iv, the inferior
pulmonary ligaments were carefully divided. The left supe

ervation. However, this resistance was much lower than that

The mechanism by which DADLE extends tissue survival
time is not at all clear. Because of the complexity of opioids
and their receptors, studies to date have primarily concen
trated on the reactions of different opioids with di?erent
receptors. Studies of the eifects of opioids on the cardio
vascular system have been performed for years, but the

25 rior vena cava was dissected, ligated, and divided. The hilum

of the left lung was approached anteriorly, and the vessels

results are very controversial. Through a Medline search, we

have found no reports relating opioid agonists to tissue
metabolism or organ preservation other than those we our 30

selves have published. Delta opioid receptors may be

and bronchus were separated by blunt dissection. The left
pulmonary artery was dissected, and a suture was placed
around it. The main pulmonary artery was transected
through the transverse sinus, and a cannula was placed in the

left pulmonary artery through the transected main pulmo

indicates that animal hibernation may be induced by a

nary artery. The suture around the left pulmonary artery was
tied, and the left atrium was partly excised to decompress the
left atrium. The left lung was ?ushed with cold preservation
solution, removed, and preserved at 4° C. for 24 hours
before functional studies. This simulates removing a lung

mechanism involving an endogenous opioid that acts
through binding to receptor sites.

planted into a second individual needing a new lung.

responsible for naturally occurring animal hibernation,
because continuous subcutaneous administration of

naloxone, an opioid antagonist, diminished the frequency
and length of hibernation bouts in ground squirrels. This

35

from a donor, said lung being preserved before being trans

Technique of isolated lung function studies.

We can only speculate about possible mechanisms by
which DADLE extends tissue survival time during hypoth

A perfusion apparatus consisting of a living host rat and
a temperature-controlled, humidi?ed chamber was used for
isolated lung function studies. The host rat was anesthetized

ermia. The effect may be related either to the inhibitory
effect of DADLE on tissue metabolism, or to the ability of

DADLE to protect tissue from various types of damage
during ischemia. The results of our study indicated that the
improved preservation may also be related to the effect of

by intraperitoneal injection of sodium pentobarbital (35-5O
45

Tidal volume of 2.5 to 3.5 ml and rate of 40 to 50 rpm were

DADLE on vasodilation, as shown by low vascular resis

tance after preservation. This supposition is also supported
by our previous experiment, in which severe reduction of
arterial blood pressure occurred after intravenous injection

mg/kg wt). The cervical trachea was cannulated, and the
animal was ventilated by a rodent respirator using room air.

50

of DADLE into anesthetized animals.

used. The right internal jugular Vein was cannulated with a
2-mm catheter. Heparin sodium 3 mg/kg was infused
intravenously, and both carotid arteries were cannulated
with 0.5-mm catheters. The catheter in the right carotid
artery was connected to a Gould pressure transducer for

arterial blood pressure monitoring. Blood from the host rat

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1. Comparison of pulmonary vascular resistance
(PVR) in three groups of rat lungs (the lower the better).
FIG. 2. Comparison of airway resistance in the same three
groups of rat lungs (lower is better).
FIG. 3. Comparison of oxygen tensions in the isolated
pulmonary vein in the three groups of rat lungs (higher is

better).
FIG. 4. Comparison of alveolar-arterial oxygen diiference
in the three groups of rat lungs (lower is better).
FIG. 5. Lung tissue wet/dryweight ratios after preserva
tion and perfusion in the same three groups (lower is better).

55

was withdrawn by gravity from the right internal jugular
vein to the pulmonary artery of the isolated lung. The
isolated lung was perfused with host venous blood by using
a hydrostatic pressure of 25 mmHg. The isolated lung was
suspended in a perfusion chamber, which was immersed in
a 37° C. water bath. Blood returned from the isolated lung
was collected in the perfusion chamber. A roller pump
returned the blood from the perfusion chamber to the left
carotid artery of the host rat. The rate of blood returning
from the chamber was adjusted to maintain satisfactory

systemic pressure.
During the perfusion period, the isolated lung was ven
65 tilated with room air at respiratory rate of 40 to 50 rpm, tidal

volume of 2.5 ml, and PEEP of 0.5 cm H2O. Such ventilation
and perfusion may, for example, be applied to an isolated

5,656,420
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lung wherein ischernia occurs during cardioplegia during

to 18.4i1.1 mmHg in Group 2; and 9.5111 to 13.3i1.2 mm

open-heart surgery and treatment of shock.
After an initial 5- to 10-minute equilibration period, blood
samples from the pulmonary artery and vein were taken
every 10 minutes for blood gas analysis. Perfusion pressure,
perfusion ?ow, airway pressure, and tidal volume were
recorded. Through the use of these parameters, puhnonary
vascular resistance and airway resistance were calculated At
the end of the experiment, lung tissue samples were taken

Hg in Group 3. Airway pressure was much higher in Group
2 (p<0.05 as compared to Group 1 and Group 3). It was also

higher in Group 3 than in Group 1.
AWR in Group 1 ranged from 2.6i0.2 to 3.7i'0.5 InmHg/
ml. It ranged from 5.5i0.3 to 7-_l'0.4 mmHg/ml in Group 2

for wet/dry weight ratio measurements.

Experimental Results
Animal groups studied
Twenty-four rats were used in this study. The rats were
divided into three groups. Group 1 (N=8) was used as
normal controls, in which the left lung was removed and

immediately transferred to the perfusion apparatus for func
tion studies. In this group, no interruption of ventilation
occurred, and interruption of lung blood perfusion was
routinely less than 10 to 20 seconds. Lung function in this

15

group was assumed to be normal. In Group 2 (N=8), the left
lung was ?ushed with 10 to 15 ml of 4° C. Euro-Collins
solution at a gravity gradient of 20 cm H20 and immersed
in 4° C. Euro-Collins solution for 24 hours. In Group 3
(N=8), the left lung was also flushed with 10 to 15 ml of 4°

oxygenation capacity in Group 2 (FIG. 3). Carbon dioxide

C. Euro-Collins solution, followed by 3 to 5 ml of 4° C.

DADLE solution (1 mg/Kg, Peninsula Lab, Behnont,

25

Calif). and then immersed in 4° C. Euro-Collins solution for.
24 hours. In Groups 2 and 3, the bronchus was clamped at

the end of inspiration to keep the lung in?ated during

storage.
Statistical analysis.
Two-way analysis of variance (ANOVA) was used for
repeated measurements. If signi?cance was established, the
Student-Newman-Keuls test was used to analyze the differ
ence between individual groups. A value of p<0.05 was
considered signi?cant. All results were expressed as

meansi-SEM.

30

35

Overall performance.
Severe pulmonary edema and hemorrhage occurred in
Group 2 (Euro-Collins solution only) within 30 minutes of

tensions in the pulmonary artery (before the blood was
oxygenated by the isolated lung) were 30i2.7 to 38i2 in
Group 1; 41i4 to 41¢? in Group 2; and 1&2 to 233 in
Group 3. Carbon dioxide tensions in the pulmonary vein
(after the blood was oxygenated by the isolated lung) were
17i'0.6 to 19i2.0 in Group 1; 17i2.5 to 23:4 in Group 2;
and 16i2 to 235 in Group 3. No statistically signi?cant
difference was found among the three groups, although
perfusion time was much shorter in Group 2.
Alveolar-arterial oxygen di?erence:

Alveolar-arterial oxygen difference (A-aO2 di?’erence)
ranged from 4.68i4.62 to 3029x1028 mmHg in Group 1.
It ranged from 44.01il0.94 to 54.88i6.16 mmHg in Group
2, and from 0.46%.46 to 23.495.45 mmHg in Group 3.
A-aO2 difference was much higher in Group 2 than in either
Group 1 or Group 3 (p<0.05, FIG. 4).

Lung tissue wet/dry weight ratio after perfusion.

perfusion. and no preparation could be perfused for more
than 30 minutes. This phenomenon did not occur in either

Group 1 (normal) or Group 3 (Euro-Collins plus DADLE),
and perfusion studies could be carried out for more than 60
minutes in these two groups. Oxygen tension and carbon
dioxide tension in the pulmonary artery and vein of the

isolated lung during the 60-minute reperfusion period

and from 3.7i0.3 to 5.0105 mmHg/ml in Group 3. AWR
was much higher in Group 2 than in Groups 1 and 3
(p<0.05). However, AWR was also higher in Group 3 than
in Group 1 after 20 minutes of perfusion (p<0.05, FIG. 2).
Blood gases in the in?ow and out?ow of the isolated lung.
Mean oxygen tensions in the pulmonary artery (before
oxygenation) were 33il.6 to 36i2.1 for Group 1; 485 to
52i7 for Group 2; and 5314.0 to 605.7 for Group 3. Mean
oxygen tensions from the pulmonary vein (after oxygenation
by the isolated lung) were 130i'l3 to 180i11 mmHg for
Group 1; 70i9.0 to 92i14 in Group 2; and 116:8.0 to
173?1 in Group 3. Oxygen tensions in Group 2 were lower
than in Group 1 and Group 3 during perfusion and became
worse when perfusion time was longer, indicating impaired

45

remained stable and were very comparable between Group

1 and Group 3. Pulmonary vascular resistance and airway
resistance were also stable during the perfusion period in

Lung tissue wet/dry weight ratio after perfusion was
6.3i0.4 in Group 1. It was 8.7i0.5 in Group 2 and 5.7i0.7
in Group 3. Tissue wet/dry weight ratio was much higher in
Group 2 than in Group 1 and Group 3 (p=0.005), even
though the perfusion time was only 30 minutes in Group 2.
There was no difference in tissue wet/dry weight ratio
between Group 1 and Group 3. See FIG. 5.
In summary, the present invention clearly demonstrates
that DADLE has a very positive e?iect on hypothermic rat

these two groups.

lung preservation. On the basis of the described experimen
tal work and other published and unpublished observations

Blood ?ow and pulmonary vascular resistance (PVR) of the
isolated lung.
Pulmonary blood ?ow ranged from 1.91i0.27 to
3.31i0.53 rnl/min in Group 1; 0.6li0.10 to 0.82i0.10
rnl/rnin in Group 2; and 1.68i0.09 to 1.94i0.21 ml/min in
Group 3. Pulmonary blood ?ow was lower in Group 2 than
in Group 1 and Group 3. In Group 1, PVR ranged from
7.5i0.8 to 14?.6 mmHg/ml/min. In Group 2. it ranged from
365 to 54:11 mmHg/ml/min; and in Group 3, it ranged
from 13.6i1 to 15i1 mmHg/ml/min. Because of very high

involving representative animals (i.e., rodents and canines),
the conclusions reached herein are believed generally appli
cable to mammals as a group. The mechanism of this effect

is not clear and deserves further study.

Composition of several preservation solutions
Collins M solution

pulmonary vascular resistance in Group 2 (p<0.05 as com

pared to Group 1 and Group 3). perfusion could not be
continued after 30 minutes, indicating severe tissue edema
in this group. No signi?cant di?erence was found in pul
monary vascular resistance between Group 1 and Group 3

(FIG. 1).
Airway pressure and resistance (AWR) of the isolated lung.
When a tidal volume of 2.5 ml was used, airway pressure

ranged from 6.4103 to 9.6i1.2 mmHg in Group 1; 13.9i0.9

Potassium
Sodium
Chloride

115 mmol/L
10 mmol/L
15 mmol/L

Phosphate

13 mmol/L

Bicarbonate

10 mmol/L

Magnesium
65

Glucose

3 mmol/L
139 mmol/L

5,656,420
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Euro-Collins solution
Sodium
Potassium
Chloride
Bicarbonate
Phosphate
Glucose

perfusion with a preservation solution comprising a preser
vation effective amount of the delta opioid DADLE ((D
10
115
15
10
58
38.5

27 mmol/L
115 mmol/L
0 mmol/L

Phosphate
Magnesium
Raf?nose

25 mmol/L
5 mmol/L

Allopurinol
Hydroxyethyl starch

mg/Kg.
10

Sodium
Potassium
Chloride

Adenosine
Glutathione

2. The method of claim 1 wherein the amount of DADLE
in the preservation solution is within the range of 1 to 10

mmol/L
g/L

University of Wisconsin solution

Lactobionate

Alaz. D-Leu5)-Enkephalin) at a hypothermic temperature.

mmol/L
mmol/L
mmol/L
mmol/L

15

30 mmol/L
100 mmol/L

1.3
09
0.1
50

g/L
g/l
g/l
g/l

5. The method of claim 4 wherein the lung is etfectively
preserved for at least 24 hours without the loss of function.
6. The method of claim 1 wherein the preservation
solution is Euro-Collins solution.
7. The method of claim 1 wherein the lung has been
removed from a donor and is being preserved before being
transplanted into a second individual needing a new lung.
8. The method of claim 1 wherein the ischemia occurs

during cardioplegia during open-heart surgery and treatment
of shock.
9. The method of claim 8 wherein the isolated lung is also

I claim:
1. A method for extending the survival time of at least one

isolated mammalian lung subjected to ischemia and
hypothermia, wherein said lung is treated during a period of

3. The method of claim 1 wherein the hypothermic
conditions include the temperature being maintained at 4° C.
4. The method of claim 2 wherein the hypothermic
conditions involve the temperature being maintained at 4° C.

ventilated during the perfusion period.
25

